Epidemiology of epilepsy
C Behr1, M A Goltzene1, G Kosmalski2
1Department of neurology, university hospital of Strasbourg, 1, place de l'Hôpital, 67000 Strasbourg, France.
Revue Neurologique
|January 13, 2016
Summary
Epilepsy affects over 50 million globally, presenting diagnostic and epidemiological challenges due to its diverse forms. This study reviews the epidemiology of syndromic and non-syndromic epilepsy, highlighting data complexities.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Epilepsy impacts over 50 million individuals worldwide, characterized by diverse clinical presentations.
- Epidemiological studies face challenges due to epilepsy's heterogeneity and evolving diagnostic criteria.
- Distinguishing between contextual seizures and chronic epilepsy is vital for accurate prevalence estimation.
Purpose of the Study:
- To provide a comprehensive overview of the epidemiology of both syndromic and non-syndromic epilepsy.
- To address the challenges in quantifying the epidemiology of rare epileptic syndromes.
- To emphasize the need for greater attention to epilepsy's prevalence and societal impact.
Main Methods:
- Review of existing epidemiological data on epilepsy.
- Analysis of factors influencing epilepsy diagnosis and classification.
- Consideration of biases in meta-analyses of epilepsy prevalence.
Main Results:
- Epilepsy is a heterogeneous disorder with significant global prevalence.
- Epidemiological quantification is complex, particularly for rare epileptic syndromes.
- Cultural factors and diagnostic evolution complicate accurate epilepsy burden assessment.
Conclusions:
- Accurate epilepsy epidemiology requires addressing diagnostic challenges and data biases.
- Rare epileptic syndromes pose unique challenges for epidemiological quantification.
- Epilepsy remains under-recognized and under-resourced, necessitating increased public health focus.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:13Seizures: Classification
2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
01:26Introduction to Epidemiology
2.5K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
2.5K
01:08Prevalence and Incidence
2.3K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K